Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 19, 2000

View Archived Issues

Xechem awarded SBIR grant for marine extremophile research

Phase I trial shows excellent safety profile for NeoRx's STR agent

Avant Immunotherapeutics reports on TP-10 progress

Tripos and Parke-Davis to jointly develop high-throughput screening methods

Inflazyme selects nonemetic PDE4 inhibitor, updates status of other products

Enzo Biochem receives grant for HBV therapy

Provigil under study for several indications

TXU (anti-CD7)-PAP possesses good pharmacokinetics, low toxicity

AxyS announces combinatorial chemistry agreement with Searle

Hollis-Eden product shows efficacy in chloroquine-resistant malaria

IL-5 receptor antagonists discovered at Structural Bioinformatics

Therapeutically useful substituted oxazolidinones emerge from R&D at AstraZeneca

New beta-carbolines are somatostatin receptor ligands and sodium channel blockers

SB discloses newest selective dopamine D3 receptor ligands

Distamycin derivatives in development at Pharmacia & Upjohn

Glycine-antagonist tetrahydroquinoline derivatives designed at Glaxo Wellcome

Byk Gulden patents new PDE4 inhibitors

Merck KGaA designs nontoxic hypoglycemic agents particularly useful for NIDDM

Efforts at DuPont to design potent and selective alphavbeta3 antagonists successful

CKD-731: new fumagillin analogue shows potential as antiangiogenic agent

Antiplatelet agent OPC-29030 appears to act by inhibiting 12-lipoxygenase translocation

FemSoft Insert now commercially available in U.S. for treatment of incontinence

Avax Technologies' O-Vax IND accepted

First clinical results with 90Y-DOTATOC indicate antitumor efficacy, some safety problems

KeraVision commences clinical trials for use of Intacs as treatment of keratoconus

Avant's cholera vaccine to enter phase IIb trial

HIV gene medicine from Enzo progresses favorably in phase I trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...